Once people don’t have justifiable access to medicine, the disease will stay longer with those people. Some will end up dying ...

GSK plc (LON:GSK – Get Free Report) insider Emma Walmsley sold 38,459 shares of the stock in a transaction dated Monday, February 17th. The stock was sold at an average price of GBX 1,418 ($17.92), ...

We recently compiled a list of the 10 Cheap Pharmaceutical Stocks to Buy According to Analysts. In this article, we are going ...

The National Agency for Food and Drug Administration and Control has made alarming discoveries in its ongoing enforcement ...

GSK Plc is a long-term underperformer among Europe’s Big Pharma stocks. And with key drug patents set to expire and vaccine ...

Bernstein analyst Florent Cespedes maintained a Buy rating on GlaxoSmithKline (GSK – Research Report) today and set a price target of £22.90.

GSK (GSK) has agreed to sell 500K doses of its avian flu vaccine to Canada to protect the country's at-risk individuals and ...

International biotechnology company GlaxoSmithKline is moving its vaccine and infectious disease research teams to Cambridge, ...

The U.S. Food and Drug Administration has approved Penmenvy (Meningococcal Groups A, B, C, W, and Y Vaccine) for active ...

Goldman Sachs analyst Rajan Sharma maintained a Hold rating on GlaxoSmithKline (GSK – Research Report) today and set a price target of £16.80.